ArticleScientific reports2026
A prognostic nomogram for all frequencies sudden sensorineural hearing loss based on the commixed index of inflammatory-immune-hemostasis-nutrition.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
All-frequencies sudden sensorineural hearing loss (AF-SSNHL) is a common otology emergency that greatly impacts patient’s quality of life. Given that inflammatory-immune-hemostasis-nutrition-related parameters are commonly reported prognostic factors, this study aimed to compare and evaluate the clinical value of such parameters to develop a prognostic nomogram. The analysis prospectively enrolled 245 patients with AF-SSNHL patients from August 2018 to May 2022. Patients were divided into training and validation cohorts randomly. The predictive values of the hematological indexes were calculated by receiver operating characteristic analysis, and predictive abilities were evaluated using logistic regression. A predictive prognostic model was developed using logistic regression and internally/external validated using calibration curves, decision curve analysis, and ROC analysis; a nomogram was constructed as its graphical representation. The prognostic nutritional index (PNI) and neutrophil lymphocyte D-dimer albumin score (NLDA) were superior to other hematological indexes in predicting the outcome of AF-SSNHL. The predictive prognostic model revealed that a high value of NLDA [odds ratio (OR), 4.363; 95% confidence interval (CI), 0.828–10.416; P < 0.05] and a low level of PNI (OR, 2.439; 95% CI, 1.188–5.006; P < 0.05) were independent risk factors for ineffective AF-SSNHL treatment. The concordance indexes for internal and external validation of the predictive model were 0.815 (95% CI, 0.754–0.875, P = 0.770) and 0.788 (95% CI, 0.663–0.913, P = 0.348), respectively. The areas under the curves of the nomogram-based predicted probabilities (nomogram scores) were 0.815 (95%CI, 0.754–0.875; P < 0.05) and 0.849 (95%CI, 0.737–0.961; P < 0.05), respectively. PNI and NLDA were superior hematological parameters and independent predictors of AF-SSNHL prognosis. Our predictive model, visualized as a nomogram based on vertigo, hearing level onset, PNI, and NLDA, may facilitate individualized prediction of treatment outcome of AF-SSNHL.Trial registration: ChiCTR1800017072, https://www.chictr.org.cn/showprojen.aspx?proj=29023, Registration Date: 07/10/2018.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.